Educational Programs
Ethics Forum
Drug Shortages — Examining the
Causes, Potential Solutions, and Effects on Patient Care
Thursday, May 17, 3:30 p.m.- 5:30 p.m.
Forum Description
Presented by the Committee on Ethics, Grievances, and
Professional Standards, the Ethics Forum alerts physicians to the
ethical implications of matters that arise in daily practice and
offers information on issues at the intersection of ethics, medicine,
and professionalism. This program will explore causes of nationwide drug
shortages, as well as potential solutions.
Audience
National drug
shortages impact many health care and health systems stakeholders. This
program will address the needs of practicing physicians, public health
professionals, and other health professionals from within group
practices to large clinical health centers.
Objectives
- Discuss causes of nationwide drugs
shortages
- Describe various potential solutions at the
local, state, and federal levels
- Cite effects that such shortages may have on
patient care
- Discuss ethical guidelines/principles that
should be considered in instances where drug rationing/alternate drug
use becomes necessary
Speakers
 |
Peter Lurie, MD, MPH
Senior Advisor in the Office of Policy and Planning in the Office of the
Commissioner at the Food and Drug Administration |
| |
|
 |
David Frank, MD, PhD
Chairs both the Medical Oncology Quality Improvement Committee and the
Pharmacy and Therapeutics Committee at the Dana-Farber Cancer
Institute |
CME Credit/Accreditation
The Massachusetts Medical Society designates this live
activity for a maximum of 2.0 AMA PRA Category 1
Credits™. Physicians should claim only the credit
commensurate with the extent of their participation in the
activity.
This activity meets the criteria of the
Massachusetts Board of Registration in Medicine for risk management
study.
The Massachusetts Medical Society is accredited
by the Accreditation Council for Continuing Medical Education to provide
continuing medical education for physicians.
Annual Education Program
The Secret Sauce: Population Health as
a Recipe for Transforming Health Care
Friday, May 18, 8:00
a.m.- 12:15 p.m.
Program Description
The
need for population health management has never been more urgent. The
number of people lacking health insurance last year climbed to more than
45 million, and almost half of the U.S. population suffers from at least
one chronic health condition. Population health, a rapidly evolving
discipline and science, reflects the evidence that what we do as
physicians and what our health care system supports today will have
consequences in preventing and treating illness and supporting
populations in the future. It considers the entire range of individual
and collective factors and conditions that have been correlated with
health status. The overarching perspective of population health is that
all stakeholders in the health care system must strive to achieve the
same goal — raise healthy people who make up healthy populations
who create productive workforces, and hence, thriving
communities.
This conference will feature world-renowned
experts who will discuss the benefits of a population health approach,
as well as exploring various applications such as global health,
epidemiology, and cutting-edge scientific research. Featured speakers
include David B. Nash, MD, MBA, dean of the Jefferson School of
Population Health, Mary Hamel, MD, Centers for Disease Control and
Prevention (CDC) Malaria Branch senior technical advisor, and Alex
“Sandy” Pentland, PhD, director of the Massachusetts
Institute of Technology (MIT) Media Lab Entrepreneurship. Moderating the
conference is Lynda Young, MD, president of the Massachusetts Medical
Society.
Audience
Population
health impacts many health care and health system stakeholders. This
program will address the needs of practicing physicians, nurses,
physician assistants, public health professionals, behaviorists,
researchers, and related health professionals from within group
practices to large clinical care centers.
Objectives
As a result of
participating in this activity, learners should be able to:
- Explain the concept of population health and
describe why a population health approach to health care
education, delivery, and policy is so important for the promotion of
health and wellness
- Describe how the “four pillars of
population health” work together to improve the health of our
society
- Relate how a recent study showed how a new
vaccine can make a major advance against one of the world’s
leading infectious diseases
- Cite two examples of cutting-edge scientific
research that can have an important impact on population
health
Faculty
Continuing Medical Education Credit
The Massachusetts Medical Society designates this live
activity for a maximum of 4.0 AMA PRA Category 1
Credits™. Physicians should claim only the credit
commensurate with the extent of their participation in the
activity.
The Massachusetts Medical Society is accredited
by the Accreditation Council for Continuing Medical Education to provide
continuing medical education for physicians.
Shattuck Luncheon and Lecture
Molecular Insights into the Gateway Sequence of Drug Abuse
Friday, May 18, 12:30 p.m.- 2:00 p.m.
Luncheon- 12:30- 1:00 p.m.
Lecture 1:00 p.m.- 2:00 p.m.
Description
Researchers concur that the studies
conducted by Drs. Eric and Denise Kandel document the mechanism of a
gateway theory for addiction, biologically and neurologically. The
theory provides evidence that early exposure to drugs can prime the
brain to the addictive behavioral effects of other drugs. They found in
their studies using mice that the animals that received nicotine both
just before and during cocaine administration showed not only a bigger
behavioral response to the harder drug (as measured by locomotor
sensitization and conditioned place preference tests), but also
significant reduction in long-term potentiation in striatal neurons.
This landmark study could help explain how tobacco products might act
as gateway drugs, increasing a person’s future likelihood of
abusing cocaine and perhaps other drugs, as well. With this knowledge of
the correlation between nicotine use and substance addiction, physicians
will be more likely to seek and analyze patient history information with
an eye toward identifying at-risk patients.
Audience
The research discussed at the 2012
Shattuck Lecture will impact clinical and behavioral health
professionals. Physicians (primary care and specialists), psychologists,
nurse practitioners, physician assistants, nurses, social workers and a
broad spectrum of health professionals will be fully engaged in this
lecture.
Objectives
As a result of participating in this
activity, learners should be able to:
- Describe the research that documents how the use of legal substances
such as cigarettes impacts one’s potential for use of illegal
substances
- Cite the neurological foundations of the “gateway”
hypothesis of drug addiction
- Explain how on a molecular level, nicotine primes the response to
cocaine thus heightening the potential for addiction
Speakers
 |
Eric R. Kandel, MD, Fred Kavli Professor and
Director, Kavli Institute for Brain Science Senior Investigator, Howard
Hughes Medical Institute Department of Neuroscience, Columbia
University |
| |
|
 |
Denise Kandel, Ph.D., Professor of Sociomedical
Sciences in Psychiatry, Columbia University College of Physicians and
Surgeons, and Chief, Department of the Epidemiology of Substance Abuse
New York State Psychiatry Institute |
CME Credit/Accreditation
The Massachusetts
Medical Society designates this live activity for a maximum of 1.0
AMA PRA Category 1 Credit™. Physicians should claim only
the credit commensurate with the extent of their participation in the
activity.
This activity meets the criteria of the Massachusetts Board of
Registration in Medicine for risk management study.
The Massachusetts Medical Society is accredited by the Accreditation
Council for Continuing Medical Education to provide continuing medical
education for physicians.
|
Governance & Leadership > Educational Programs 
